This study is part of the clinical evaluation of SEBBIN silicone gel-filled testicular implants, included in the technical file of the device. The aim of the study is to gather additional data about the safety and effectiveness of the device.

Inclusion Criteria:

• The patient is an adult or a child at the time of implant placement with SEBBIN implant.
• The patient is candidate to a unilateral or bilateral testicular implant placement with SEBBIN implant.
• The patient has been informed of the study, has read the patient information letter and -provided oral consent.

Exclusion Criteria:

• The patient has silicone implants somewhere else than in the scrotal sac.

• The patient was diagnosed with one of the following pathologies:

  • Systemic lupus erythematous, Sjogren syndrome, scleroderma, polymyositis, or any other connective tissue disease.
  • Rheumatoid arthritis, crystalline arthritis, infectious arthritis, spondyloarthropathies, or any other inflammatory arthritic disease.
  • Arthritis, fibromyalgia, chronic fatigue syndrome, or any other mechanic or degenerative non-inflammatory rheumatic disease.

• The patient has a pathology that could delay healing.

• Custom-designed implants are used for surgery.

The intended target population for the silicone gel-filled testicular implants of Groupe SEBBIN is any patient (children or adults) with agenesis or testicular atrophy, undescended testicle, testicular tumour, epididymitis / orchitis, or a trauma, for whom an orchidectomy with placement of a testicular prosthesis is indicated. Testicular implants are also indicated for sex reassignment surgeries.